David O. Bates

Incidence and preventability of adverse drug events in nursing homes

Jerry H. Gurwitz, Terry S. Field, Jerry Avorn et al. · The American Journal of Medicine · 2000 · 653 citations

Pharmacy, Pharmacotherapy, Patient Safety +11

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

Eva Havrdová, Steven Galetta, Michael Hutchinson et al. · The Lancet Neurology · 2009 · 473 citations

Life Sciences, Neurology, Pharmacotherapy +10

Neurologic and neuropsychological morbidity following major surgery: comparison of coronary artery bypass and peripheral vascular surgery.

Pamela J. Shaw, David O. Bates, N.E.F. Cartlidge et al. · Stroke · 1987 · 463 citations · Full text

Medicine, Neurology, Surgery +17

VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant

Jeanette Woolard, Wenying Wang, Heather S. Bevan et al. · Cancer Research · 2004 · 461 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

Early neurological complications of coronary artery bypass surgery.

Pamela J. Shaw, David O. Bates, N.E.F. Cartlidge et al. · BMJ · 1985 · 353 citations · Full text

Medicine, Neurology, Surgery +17